Scientific Program
| Wednesday, 7 May 2025 | |||||||||||||||||||||||||
| 18:00-19:00 | Welcome Reception and Networking Exhibit and Poster Hall Open |
||||||||||||||||||||||||
| Thursday, 8 May 2025 | |||||||||||||||||||||||||
| 08:00-09:00 | Congress Welcome and Invited Award Lectures • Welcome from IAPRD President and Congress Leaders • IAPRD Lifetime Achievement Award Lecture • IAPRD Melvin Yahr Award Lecture |
||||||||||||||||||||||||
| 09:00-10:30 | General Session 1: Pathophysiology of Parkinson’s and Related Disorders Chair: Serge Przedborski (New York, USA) Chair: Ryan Uitti (Jacksonville, USA) |
Workshop 1: PRD Essentials – A Practical Approach to Diagnosing and Treating Parkinson’s Disease and Related Disorders Part I: Hypokinetic Disorders |
|||||||||||||||||||||||
| 09:00-09:30 | 1a: Synuclein-based biomarkers: what they do and do not tell us Andrew Siderowf (Philadelphia, USA) |
1a: Diagnosis and diagnostic testing in Parkinson’s disease Vicki Shanker (New York, USA) |
|||||||||||||||||||||||
| 09:30-10:00 | 1b: Are we forgetting tau as a biomarker? Giorgia Melli (Lugano, Switzerland) |
1b: PD treatment spectrum—from de novo to advanced Matt Swan (New York, USA) |
|||||||||||||||||||||||
| 10:00-10:30 | 1c: Making sense of biomarkers and co-pathology Alice Chen-Plotkin (Philadelphia, USA) |
1c: Diagnostic and treatment pearls in atypical parkinsonism Stephen Reich (Baltimore, USA) |
|||||||||||||||||||||||
| 10:30-11:00 | Coffee Break (Exhibit and Poster Hall open) | ||||||||||||||||||||||||
| 11:00-12:30 | Parallel Session 1: From Genetics to Targeted Therapy Chair: Andreas Puschmann (Lund, Sweden) Chair: Huifang Shang (Chengdu, China) |
Parallel Session 2: Botulinum Neurotoxin Opportunities and Techniques Chair: Mark Lew (Los Angeles, USA) Chair: Steven Frucht (New York, USA) |
Workshop 1: continued Part II: Hyperkinetic Disorders |
||||||||||||||||||||||
| 11:00-11:30 | 1a: Genetic testing for parkinsonism Roy Alcalay (New York, USA; Tel Aviv, Israel) |
2a: Choosing specific botulinum toxins for selected indications Barbara Karp (Bethesda, USA) |
1d: Common pediatric movement disorders and the continuum to adulthood Emmanuel Roze (Paris, France) |
||||||||||||||||||||||
| 11:30-12:00 | 1b: Genetic testing for ataxia Mario Cornejo Olivas (Lima, Peru) |
2b: Botulinum toxin use in Parkinson’s disease Anna Castagna (Milan, Italy) |
1e: Dystonia classification, genetics, and treatment implications Rachel Saunders-Pullman (New York, USA) |
||||||||||||||||||||||
| 12:00-12:30 | 1c: Testing and care for Friedreich ataxia Sylvia Boesch (Innsbruck, Austria) |
2c: Botulinum neurotoxin use in task-specific dystonia Steven Frucht (New York, USA) |
1f: Phenomenology and treatment of hyperkinetic disorders Andres Deik (Philadelphia, USA) |
||||||||||||||||||||||
| 12:30-14:30 |
Lunch Break (Exhibit and Poster Hall open) |
||||||||||||||||||||||||
| 14:30-16:00 | Parallel Session 3: It Takes a Village: Comprehensive Approach to Caring for Parkinson’s Chair: Ryan Uitti (Jacksonville, USA) Chair: Maja Trošt (Ljubljana, Slovenia) |
Parallel Session 4: Paroxysmal and Episodic Movement Disorders Chair: Daniel Truong (Fountain Valley, USA) Chair: Pramod Pal (Bangalore, India) |
Workshop 2: Deep Brain Stimulation Skills | ||||||||||||||||||||||
| 14:30-15:00 | 3a: Multidisciplinary team care Anhar Hassan (Dublin, Ireland) |
4a: Neurophysiological and genetic evaluation Roberto Erro (Salerno, Italy) |
|
||||||||||||||||||||||
| 15:00-15:30 | 3b: Rehabilitation Theresa Ellis (Boston, USA) |
4b: Autoimmune underpinnings Bettina Balint (Zurich, Switzerland) |
|||||||||||||||||||||||
| 15:30-16:00 | 3c: Palliative care and improving quality of life Anette Schrag (London, UK) |
4c: Treatment options Hyder Jinnah (Atlanta, USA) |
|||||||||||||||||||||||
| 16:00-17:00 | Coffee Break (Exhibit and Poster Hall open) Coffee with the Professor |
||||||||||||||||||||||||
| 16:00-17:00 | Guided Poster Tours | ||||||||||||||||||||||||
| 17:00-18:30 | General Session 2: Driving Scientific Discovery With Bioinformatics, AI and Innovation Chair: Andreas Puschmann (Lund, Sweden) Chair: Angelo Antonini (Padua, Italy) |
||||||||||||||||||||||||
| 17:00-17:30 | 2a: Big data and the bioinformatics revolution in diagnostics and beyond Michael Zech (Munich, Germany) |
||||||||||||||||||||||||
| 17:30-18:00 | 2b: Artificial intelligence and clinical discovery: predictive AI, modeling, clinical decision support and personalized medicine Maria Chiara Malaguti (Trento, Italy) |
||||||||||||||||||||||||
| 18:00-18:30 | 2c: Generative AI and innovative monitoring of Parkinson’s and related disorders Michael Schwarzschild (Boston, USA) |
||||||||||||||||||||||||
| 18:45-22:00 | Faculty Dinner | ||||||||||||||||||||||||
| Friday, 9 May 2025 | |||||||||||||||||||||||||
| 08:00-09:00 |
Exhibit and Poster Hall Open |
IAPRD General Business Meeting | |||||||||||||||||||||||
| 08:00-09:00 | Guided Poster Tours | ||||||||||||||||||||||||
| 09:00-10:30 | General Session 3: Novel and Translational Therapeutics for Parkinson’s and Related Disorders Chair: Shinsuke Fujioka (Fukuoka, Japan) Chair: Elena Moro (Grenoble, France) |
||||||||||||||||||||||||
| 09:00-09:30 | 3a: Novel cell therapies Ryosuke Takahashi (Kyoto, Japan) |
||||||||||||||||||||||||
| 09:30-10:00 | 3b: Therapeutic strategies based on inflammation/immunotherapy Malú Gámez Tansey (Gainsville, USA) |
||||||||||||||||||||||||
| 10:00-10:30 | 3c: Antidiabetic and other potential neurorestorative agents Jingchuan Guo (Gainesville, USA) |
||||||||||||||||||||||||
| 10:30-11:00 | Coffee Break | ||||||||||||||||||||||||
| 11:00-12:30 | Parallel Session 5: Update on Neuromodulation for Hypo- and Hyperkinetic Disorders Chair: Alfonso Fasano (Toronto, Canada) Chair: Elena Moro (Grenoble, France) |
Parallel Session 6: Defining and Treating Atypical Parkinsonism Chair: Lawrence Honig (New York, USA) Chair: Emelia Gatto (Buenos Aires, Argentina) |
Workshop 3: Botulinum Toxin Injection Workshop Chair: Alberto Albanese (MIlan, Italy) Chair: David Simpson (New York, USA) |
||||||||||||||||||||||
| 11:00-11:30 | 5a: MR- guided focused ultrasound Gordon Baltuch (New York, USA) |
6a: Differentiating PSP, MSA, and corticobasal syndrome Ai-Huey Tan (Kuala Lumpur, Malaysia) |
3a: Clinical utility of botulinum neurotoxins 3b: Techniques for muscle localization 3c: Injection demonstration video cases |
||||||||||||||||||||||
| 11:30-12:00 | 5b: Deep brain stimulation Alexandra Boogers (Leuven, Belgium) |
6b: Therapeutic approaches Morris Huw (London, UK) |
|||||||||||||||||||||||
| 12:00-12:30 | 5c: Neuromodulatory neurostimulation (TMS, tDCS, TAS, TUS, TI) Robert Chen (Toronto, Canada) |
6c: Debate: Is neuropathology the gold standard for diagnosis? Yes/No Paola Sandroni (Rochester, USA) |
|||||||||||||||||||||||
| 12:30-14:30 |
Lunch Break (Exhibit and Poster Hall Open) |
||||||||||||||||||||||||
| 14:30-16:00 | Parallel Session 7: Management of Advanced Parkinson’s Chair: Zoltan Mari (Las Vegas, USA) Chair: Jinyoung Youn (Seoul, Korea) |
Parallel Session 8: Management of the Hyperkinetic Movement Disorders Chair: Karen Frei (Loma Linda, USA) Chair: Anhar Hassan (Dublin, Ireland) |
Workshop 4: Diagnostic Testing for Parkinson’s Disease and Parkinsonism Chair: Marie Saint-Hilaire (Boston, USA) Chair: Roy Alcalay (New York, USA; Tel Aviv, Israel) |
||||||||||||||||||||||
| 14:30-15:00 | 7a: Defining advanced PD and treatment needs Indu Subramanian (Los Angeles, USA) |
8a: Tardive syndromes Roongroj Bhidayasiri (Bangkok, Thailand) |
4a: Utility and interpretation of skin biopsy testing for alpha-synuclein 4b: Differential diagnosis with CSF diagnosis markers 4c: Current and emerging imaging markers and techniques 4d: Neurophysiology |
||||||||||||||||||||||
| 15:00-15:30 | 7b: Cognitive and psychiatric issues Daniel Weintraub (Philadelphia, USA) |
8b: Huntington disease Sarah Tabrizi (London, UK) |
|||||||||||||||||||||||
| 15:30-16:00 | 7c: Motor fluctuations Rajesh Pahwa (Kansas City, USA) |
8c: Myoclonus and Tics Christos Ganos (Toronto, Canada) |
|||||||||||||||||||||||
| 16:00-17:00 |
Coffee Break (Exhibit and Poster Hall open) |
||||||||||||||||||||||||
| 16:00-17:00 | Guided Poster Tours | ||||||||||||||||||||||||
| 17:00-18:30 | General Session 4: Innovative Advances in Neuromodulation Chair: Joohi Jimenez-Shahed (New York, USA) Chair: Rubens Cury (Sao Paolo, Brazil) |
||||||||||||||||||||||||
| 17:00-17:30 | 4a: Closing the loop in DBS Helen Bronte-Stewart (Stanford, USA) |
||||||||||||||||||||||||
| 17:30-18:00 | 4b: Connecting the dots: connectomic DBS Andreas Horn (Boston, USA) |
||||||||||||||||||||||||
| 18:00-18:30 | 4c: Are we ready for automated DBS programming? Svjetlana Miocinovic (Atlanta, USA) |
||||||||||||||||||||||||
| Saturday, 10 May 2025 | |||||||||||||||||||||||||
| 07:45-08:15 | Morning Coffee | ||||||||||||||||||||||||
| 08:00-09:00 | Guided Poster Tours | ||||||||||||||||||||||||
| 09:15-11:15 | General Session 5: The Grand Video Challenge of Movement Disorders Video Session Moderator/Master of Ceremonies: Hubert Fernandez (Cleveland, USA) Discussant: Michael Zech (Munich, Germany) Discussant: Ruth Walker (New York, USA) Discussant: Pramod Pal (Bangalore, India) Discussant: Bettina Balint (Zurich, Switzerland) Discussant: Ai-Huey Tan (Kuala Lumpur, Malaysia) Discussant: Mahajan Abhimanyu (Cincinnati, USA) |
||||||||||||||||||||||||
| 11:15-11:45 |
Best Papers in Parkinsonism and Related Disorders and Clinical Parkinsonism and Related Disorders |
||||||||||||||||||||||||
| 11:45-12:30 | IAPRD 2025 Congress Awards and Closing Ceremony | ||||||||||||||||||||||||